347 related articles for article (PubMed ID: 24565885)
1. Synthetic cathinones ("bath salts").
Banks ML; Worst TJ; Rusyniak DE; Sprague JE
J Emerg Med; 2014 May; 46(5):632-42. PubMed ID: 24565885
[TBL] [Abstract][Full Text] [Related]
2. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
German CL; Fleckenstein AE; Hanson GR
Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
[TBL] [Abstract][Full Text] [Related]
3. Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'.
Wood MR; Lalancette RA; Bernal I
Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):32-8. PubMed ID: 25567572
[TBL] [Abstract][Full Text] [Related]
4. The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.
Abbott R; Smith DE
J Psychoactive Drugs; 2015; 47(5):368-71. PubMed ID: 26579784
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker use for toxicity from "bath salts".
Richards JR; Laurin EG; Albertson TE
J Emerg Med; 2015 Feb; 48(2):e45-6. PubMed ID: 25453853
[No Abstract] [Full Text] [Related]
6. Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones ("Bath Salts") in Recreational Users.
Ashrafioun L; Bonadio FA; Baik KD; Bradbury SL; Carhart VL; Cross NA; Davis AK; Feuille M; Harper AR; Lackey JH; Lang B; Lauritsen KJ; Leith J; Osborn LA; Rosenberg H; Stock J; Zaturenskaya M
J Psychoactive Drugs; 2016; 48(5):336-343. PubMed ID: 27681583
[TBL] [Abstract][Full Text] [Related]
7. Psychoactive "bath salts": not so soothing.
Baumann MH; Partilla JS; Lehner KR
Eur J Pharmacol; 2013 Jan; 698(1-3):1-5. PubMed ID: 23178799
[TBL] [Abstract][Full Text] [Related]
8. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
Coppola M; Mondola R
Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of "bath salts" purchased from California stores and the internet.
Schneir A; Ly BT; Casagrande K; Darracq M; Offerman SR; Thornton S; Smollin C; Vohra R; Rangun C; Tomaszewski C; Gerona RR
Clin Toxicol (Phila); 2014 Aug; 52(7):651-8. PubMed ID: 25089721
[TBL] [Abstract][Full Text] [Related]
10. Acute psychosis induced by bath salts: a case report with clinical and forensic implications.
Stoica MV; Felthous AR
J Forensic Sci; 2013 Mar; 58(2):530-3. PubMed ID: 23317451
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.
Spiller HA; Ryan ML; Weston RG; Jansen J
Clin Toxicol (Phila); 2011 Jul; 49(6):499-505. PubMed ID: 21824061
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cathinones: "a khat and mouse game".
Katz DP; Bhattacharya D; Bhattacharya S; Deruiter J; Clark CR; Suppiramaniam V; Dhanasekaran M
Toxicol Lett; 2014 Sep; 229(2):349-56. PubMed ID: 24973490
[TBL] [Abstract][Full Text] [Related]
13. New and Emerging Illicit Psychoactive Substances.
Graddy R; Buresh ME; Rastegar DA
Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
[TBL] [Abstract][Full Text] [Related]
14. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
[TBL] [Abstract][Full Text] [Related]
15. Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone.
Ross EA; Reisfield GM; Watson MC; Chronister CW; Goldberger BA
Am J Med; 2012 Sep; 125(9):854-8. PubMed ID: 22682791
[TBL] [Abstract][Full Text] [Related]
16. Abuse potential and toxicity of the synthetic cathinones (i.e., "Bath salts").
Riley AL; Nelson KH; To P; López-Arnau R; Xu P; Wang D; Wang Y; Shen HW; Kuhn DM; Angoa-Perez M; Anneken JH; Muskiewicz D; Hall FS
Neurosci Biobehav Rev; 2020 Mar; 110():150-173. PubMed ID: 31101438
[TBL] [Abstract][Full Text] [Related]
17. Baths salts, spice, and related designer drugs: the science behind the headlines.
Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
[TBL] [Abstract][Full Text] [Related]
18. Bath Salts to Therapies: Can Separation of Adverse and Therapeutic Effects of Substituted Cathinones Lead to a Medication for Psychostimulant Use Disorder?
Unterwald EM; Rawls SM
J Pharmacol Exp Ther; 2023 Jun; 385(3):159-161. PubMed ID: 37197988
[No Abstract] [Full Text] [Related]
19. Designer drugs 2015: assessment and management.
Weaver MF; Hopper JA; Gunderson EW
Addict Sci Clin Pract; 2015 Mar; 10(1):8. PubMed ID: 25928069
[TBL] [Abstract][Full Text] [Related]
20. Stimulant and Designer Drug Use: Primary Care Management.
Klega AE; Keehbauch JT
Am Fam Physician; 2018 Jul; 98(2):85-92. PubMed ID: 30215997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
